Jean-Marie Boeynaems Selected Research

purinoceptor P2Y6

1/2017	P2Y6 Receptor Activation Promotes Inflammation and Tissue Remodeling in Pulmonary Fibrosis.
1/2016	Purinergic P2Y6 receptors heterodimerize with angiotensin AT1 receptors to promote angiotensin II-induced hypertension.
1/2016	Loss of Mouse P2Y6 Nucleotide Receptor Is Associated with Physiological Macrocardia and Amplified Pathological Cardiac Hypertrophy.
1/2016	Central Role of P2Y6 UDP Receptor in Arteriolar Myogenic Tone.
10/2011	The P2Y(6) receptor stimulates bone resorption by osteoclasts.
2/2011	Selective induction of endothelial P2Y6 nucleotide receptor promotes vascular inflammation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jean-Marie Boeynaems Research Topics

Disease

12	Inflammation (Inflammations) 05/2017 - 04/2002
4	Fibrosis (Cirrhosis) 05/2017 - 10/2012
3	Hypertrophy 01/2016 - 10/2012
3	Ischemia 01/2016 - 09/2012
3	Asthma (Bronchial Asthma) 01/2012 - 09/2010
3	Cystic Fibrosis (Mucoviscidosis) 01/2012 - 12/2006
3	Pneumonia (Pneumonitis) 07/2011 - 07/2010
2	Lung Diseases (Lung Disease) 05/2017 - 01/2017
2	Pulmonary Fibrosis (Fibrosing Alveolitis) 05/2017 - 01/2017
2	Lung Injury 01/2017 - 07/2010
2	Atherosclerosis 05/2015 - 11/2013
2	Osteoporosis 06/2013 - 01/2012
2	Neoplasms (Cancer) 10/2010 - 08/2009
2	Astrocytoma (Pilocytic Astrocytoma) 01/2010 - 07/2005
1	Hypertension (High Blood Pressure) 01/2016
1	Cardiomegaly (Heart Hypertrophy) 01/2016
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2016
1	Hyperplasia 01/2016
1	Atherosclerotic Plaque (Atheroma) 05/2015
1	Infarction (Infarctions) 02/2015
1	Myocardial Infarction 02/2015
1	Uveitis 01/2015
1	Intestinal Pseudo-Obstruction (Intestinal Pseudoobstruction) 09/2014
1	Dyslipidemias (Dyslipidemia) 11/2013
1	Infections 01/2012
1	Virus Diseases (Viral Diseases) 01/2012
1	Bone Resorption 10/2011
1	Airway Remodeling 07/2011
1	Eosinophilia 07/2011
1	Emphysema 07/2010
1	Thrombosis (Thrombus) 07/2010
1	Dry Eye Syndromes (Dry Eye Syndrome) 07/2010
1	Chronic Obstructive Pulmonary Disease (COPD) 07/2010
1	Alzheimer Disease (Alzheimer's Disease) 01/2010
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2010
1	Necrosis 04/2005
1	Substance-Related Disorders (Drug Abuse) 01/2005

Drug/Important Bio-Agent (IBA)

15	NucleotidesIBA 05/2017 - 04/2005
6	purinoceptor P2Y6IBA 01/2017 - 02/2011
5	Purinergic Receptors (Receptors, Purine)IBA 05/2017 - 07/2010
4	Adenosine Triphosphate (ATP)IBA 01/2012 - 07/2010
3	Purinergic P2Y2 ReceptorsIBA 05/2017 - 09/2010
2	Bleomycin (Blenoxane)FDA LinkGeneric 05/2017 - 01/2017
2	N,N''- 1,4- butanediylbis(N'- (3- isothiocyanatophenyl))thioureaIBA 01/2016 - 07/2011
2	CholesterolIBA 05/2015 - 11/2013
2	LipidsIBA 09/2014 - 11/2013
2	Adenosine Diphosphate (ADP)IBA 09/2014 - 01/2012
1	Angiotensin IIIBA 01/2016
1	Heterotrimeric GTP-Binding Proteins (Heterotrimeric G-Proteins)IBA 01/2016
1	ArrestinIBA 01/2016
1	AngiotensinsIBA 01/2016
1	Guanine NucleotidesIBA 01/2016
1	Carrier Proteins (Binding Protein)IBA 01/2016
1	GTP-Binding Proteins (G-Protein)IBA 01/2016
1	Uridine Diphosphate (UDP)IBA 01/2016
1	UracilIBA 01/2016
1	Isoproterenol (Isoprenaline)FDA LinkGeneric 01/2016
1	SterolsIBA 05/2015
1	ApolipoproteinsIBA 05/2015
1	Apolipoproteins E (ApoE)IBA 05/2015
1	HDL LipoproteinsIBA 05/2015
1	Endothelin-1 (Endothelin 1)IBA 02/2015
1	Dietary CholesterolIBA 11/2013
1	purinoceptor P2Y4IBA 10/2012
1	Uridine Triphosphate (UTP)IBA 01/2012
1	Estrogens (Estrogen)FDA Link 01/2012
1	ovalbumin-alumIBA 07/2011
1	CytokinesIBA 07/2011
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 09/2010
1	SmokeIBA 07/2010
1	Pharmaceutical PreparationsIBA 07/2010
1	LithiumIBA 01/2010
1	phosphonic acidIBA 01/2010
1	AcidsIBA 01/2010
1	CalciumIBA 01/2010
1	SaltsIBA 01/2010
1	Xylenes (Xylene)IBA 01/2010
1	tau Proteins (tau Protein)IBA 01/2010
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 07/2007
1	ProstaglandinsIBA 07/2007
1	EnzymesIBA 07/2007
1	Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)IBA 12/2006
1	Purinergic P2Y1 ReceptorsIBA 07/2005
1	Proteins (Proteins, Gene)FDA Link 07/2005
1	Type C PhospholipasesIBA 07/2005
1	pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acidIBA 07/2005
1	methylthio-ADPIBA 07/2005
1	MRS 2211IBA 07/2005
1	G protein alpha 16IBA 07/2005
1	Ion Channels (Ion Channel)IBA 04/2005
1	Naloxone (Narcan)FDA LinkGeneric 01/2005
1	TilidineIBA 01/2005
1	Opioid Analgesics (Opioids)IBA 01/2005
1	Cell Surface ReceptorsIBA 04/2002

Therapy/Procedure

3	Therapeutics 06/2013 - 08/2009
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 05/2015
1	Ligation 02/2015
1	Ovariectomy (Oophorectomy) 01/2012